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Objective: Diagnostic rates of unknown primary head and neck carcinoma (UPHNC) 
using lingual tonsillectomy (LT) are highly variable. This study sought to determine the 
diagnostic value of LT in UPHNC identification using strict inclusion criteria and definitions 
to produce a more accurate estimate of diagnosis rate.
Methods: In this retrospective chart review, records of patients who underwent LT for 
UPHNC were reviewed. Inclusion criteria included absence of suspicious findings on 
physical exam and positron emission tomography-computed tomography as well as 
negative biopsies after panendoscopy and palatine tonsillectomy. Following inclusion 
criteria, 16 patients were reviewed. A systematic literature review on LT for the workup 
of CUP was also performed.
results: LT was performed using transoral robotic surgery (TORS), transoral laser 
microsurgery (TLM), or transoral microsurgery with cautery (TMC). Following LT, primary 
tumor was identified in 4 patients out of 16. Detection rate by technique was 1/6, 2/7, 
and 1/3 for TORS, TLM, and TMC respectively. Postoperative bleeding occurred in three 
patients (19%); however, this was not related to the LT. Following literature review, 12 
studies were identified; however, only 3 had enough data to compare against. All three 
studies had a cohort with suspicious findings on clinical exam. A total of 34 patients 
had a negative workup, with no suspicious findings on clinical exam and subsequently 
received an LT.
conclusion: This study suggests that LT should be considered initially in the diagnostic 
algorithm for UPHNC. This study can increase the patient size in this cohort by approx-
imately 47%.
Keywords: squamous cell carcinoma, unknown primary, lingual tonsillectomy, transoral robotic surgery, transoral 
laser microsurgery
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sUMMarY
•	 The	rate	of	unknown	primary	detection	from	LT	in	the	liter-





















a	 diagnostic	 rate	 of	 7–38%	 (7,	 8).	 Once	 imaging	 is	 complete,	
panendoscopy	with	tumor	mapping	is	performed,	with	or	without	
palatine	tonsillectomy.	Reported	diagnostic	rates	of	tumor	map-
ping	 are	 approximately	 20–50%	when	biopsies	 can	be	 targeted	
with	 PET-CT;	 however,	 diagnostic	 rates	 markedly	 decrease	 to	
9–29%	when	PET-CT	is	negative	(5,	6,	9,	10).
The	treatment	of	UPHNC	entails	neck	dissection	plus	chemo-
radiation	 (CRT),	 neck	 dissection	 plus	 radiation,	 primary	CRT,	
or	primary	 radiation.	Because	a	primary	 site	 cannot	be	 identi-
fied,	 radiation	 fields	 are	 broad	 to	 target	 the	 entire	 oropharynx	



































patients	 were	 first	 evaluated	 in	 the	 outpatient	 setting	 and	 had	
negative	 findings	 on	 physical	 exam,	 flexible	 laryngoscopy,	 and	
PET-CT.	To	fit	our	inclusion	criteria	for	unknown	primary	based	
on	PET-CT,	the	imaging	study	had	to	be	entirely	negative	with-
out	any	 suggestion	of	a	primary	 site.	Further	 inclusion	criteria	
required	patients	to	have	undergone	LT	in	addition	to	standard	


















For	 TLM	 and	 transoral	 microsurgery	 with	 cautery	 (TMC)	













unknown	 primary,	 LT,	 SCC,	 and	TORS	 or	 TLM	were	 used	 to	
identify	studies.	Studies	that	included	less	than	five	patients	were	
Table 1 | Patient demographics and comorbidities.
age (years) Tobacco abuse Tobacco abuse etOh abuse comorbidities
Case 1 56–60 40 packs/year 40 packs/year 6 drinks/day None
Case 2 56–60 None None None None
Case 3 56–60 None None None None
Case 4 61–65 40 packs/year 40 packs/year None T2DM, prostate CA, HTN, obesity
Case 5 66–70 40 packs/year 40 packs/year None Stroke, CAD, HTN, HLD, atrial flutter
Case 6 41–45 25 packs/year 25 packs/year None Anxiety, depression
Case 7 66–70 None None 2 drinks/day Hearing loss
Case 8 56–60 None None None None
Case 9 51–55 10 packs/year 10 packs/year None None
Case 10 46–50 None None None HLD, asthma
Case 11 51–55 20 packs/year 20 packs/year 1 drink/day T1DM, osteoarthritis
Table 2 | Patient nodal status, surgery, and results.
nodal 
status
surgery lingual tonsil concurrent neck 
dissection
Tumor size Margins p16
Case 1 R N2a Transoral laser microsurgery (TLM) CO2 Positive N 0.5 cm × 0.4 cm Negative Negative
Case 2 R N2 TLM CO2b Negative Y N/A N/A Positive
Case 3 R N2 TLM CO2 Negative N N/A N/A Positive
Case 4 L N2 TLM CO2 Negative Y N/A N/A Positive
Case 5 L N3 TLM CO2b Negative Nc N/A N/A Negative
Case 6 L N2 TLM CO2 Negative N N/A N/A Positive
Case 7 L N1B TLM CO2 Positive N Small foci Negative Positive
Case 8 R N2 Transoral robotic surgery (TORS)b Negative N N/A N/A Positive
Case 9 R N2 TORSb Negative Y N/A N/A Positive
Case 10 R N2 Transoral microsurgery with cautery (TMC) Negative Nc N/A N/A Positive
Case 11 R N2 TMCb Positive Nc Undetermined Positive: deep 
margin
Positive
Case 12 R N2 TORS Negative Y N/A N/A Positive
Case 13 L N2 TORSb Positive Y 0.3 cmd Negative Positive
Case 14 L N2 TORS Negative Y N/A N/A Positive
Case 15 R N2 TORSb Negative Y N/A N/A Negative
Case 16 R N2 TMCb Negative N N/A N/A Negative
aLiver and axillary metastasis.
bBilateral lingual tonsillectomy.
cNeck dissection as a second procedure.
dIn the largest diameter.
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Fifteen	patients	presented	with	a	 level	 II	and/or	 level	 III	cervi-
cal	node,	and	one	patient	presented	with	a	 level	I	 lymph	node.	
There	were	no	 localizing	ENT	 symptoms,	 and	 all	 patients	 had	
negative	 findings	 on	 physical	 exam	 and	 flexible	 laryngoscopy.	





Lingual	 tonsillectomy	was	 performed	 either	 during	 the	 stand-








a	detection	 rate	of	 25%	 (4/16).	All	detectable	 carcinomas	were	










surgery to last follow-up 
(months)
Case 1 RT AWD 8.7
Case 2 RT NED 23.6
Case 3 CRT NED 21.7
Case 4 CRT NED 12.3
Case 5 None NED 7.1
Case 6 CRT NED 52.6
Case 7 CRT NED 38.2
Case 8 CRT DSD 30.7
Case 9 CRT NED 27.5
Case 10 None NED 12.4
Case 11 RT NED 5.5
Case 12 None NED 84.3
Case 13 RT NED 3.6
Case 14 None NED 19.9
Case 15 None NED 9.8
Case 16 CRT NED 6.5
RT, radiation therapy; CRT, chemoradiation; AWD, alive with disease; NED, no evidence 
of disease; DSD, died without disease.
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on	pathology	 and	margin	 status.	Thus,	methods	 for	 increasing	
primary	site	identification	are	of	great	interest.
While	 there	 is	 currently	 no	 universal	 guideline	 for	workup	
of	 unknown	 primary	 SCC	 of	 the	 head	 and	 neck,	 a	 national	
guideline	is	present	in	the	United	Kingdom.	Typically,	a	workup	
starts	with	 a	 full	 history	 and	physical	 exam	with	flexible	 fiber	
optic	laryngoscopy.	PET-CT	is	often	incorporated	and	presents	
a	diagnostic	rate	ranging	from	7	to	38%	(7,	8).	However,	a	major	
limitation	 of	 PET-CT	 is	 that	 tumors	 less	 than	 1  cm	 in	 diam-
eter	are	not	 reliably	detected	 (21).	 In	a	 study	of	111	 identified	
unknown	primary	 tumors,	 the	 average	 diameter	was	 1.15  cm,	
and	57%	of	tumors	were	less	than	1 cm	in	diameter	(19).	These	
data	 suggest	 that	more	 than	half	 of	unknown	primary	 tumors	
may	be	below	PET-CT	detection	level,	and	their	reported	value	






Once	 imaging	 is	 complete,	 panendoscopy	 with	 tumor	
mapping	 is	 traditionally	 performed.	When	PET-CT	 is	 able	 to	
provide	 targeted	 biopsies,	 diagnostic	 rates	 of	 tumor	mapping	










infrequent	presentation.	We	 report	 an	overall	detection	 rate	of	
25%	with	LT.	This	detection	rate	 is	 lower	than	most	previously	




In	 a	 study	 by	 Mehta	 et  al.,	 LT	 with	 TORS	 yielded	 a	 90%	
detection	rate;	however,	40%	of	these	had	positive	BOT	PET-CT	
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physical	 exam	 findings,	 56.5%	 of	which	were	 confirmed	 to	 be	
cancer,	 and	34%	of	which	had	 suspicious	findings	on	PET-CT,	








However,	 a	 counterpoint	 would	 be	 that	 PET-CT	 carries	 a	
false	positive	rate	up	to	37%,	thus	patients	with	positive	PET-CT	









Most	 recently,	 a	 systematic	 review	 by	 Fu	 et  al.	 reported	 LT	
identifying	primary	tumor	in	72%	(18/25)	patients	with	no	find-
ings	(19).	The	cohort	size	included	in	the	systematic	review	was	
limited	 by	 heterogeneity	 of	 preoperative	 workups,	 definitions	
of	 unknown	primary,	 and	 limited	 information	 regarding	 exact	
surgical	techniques	utilized	in	the	literature.	A	prospective,	multi-
institutional	 trial	 utilizing	 homogenous	 preoperative	 workup,	
imaging,	and	surgical	 techniques	would	be	required	 to	present	
an	accurate	UPHNC	diagnosis	from	LT.
In	 accordance	 with	 current	 changes	 in	 the	 epidemiological	





Despite	a	 large	range	of	 tumor	 isolation	reported	 from	LT,	
it	is	a	useful	adjunct	in	UPHNC	identification	and	carries	low	
risk	 of	morbidity.	The	most	 common	 adverse	 event	 from	 LT	
is	 postoperative	 bleeding	 in	 5%	 of	 cases	 (19).	 In	 this	 study,	
although	three	patients	had	bleeding	events	after	surgery,	none	
were	related	to	the	LT	itself.	Given	that	all	reported	LT	UPHNC	
diagnostic	 rates	 exceed	 this	 value,	 it	 may	 be	 reasonable	 to	













all	 suspicious	findings	were	excluded,	43	cases	 from	the	 three	




of	 this	 study	 is	 that	 three	 differing	 resection	 techniques	were	
utilized,	 although	 successful	 identification	 of	 a	 primary	 was	
achieved	with	each	technique.	Of	note,	seven	patients	had	a	neck	
dissection	 concurrent	 with	 the	 tonsillectomy,	 three	 patients	
had	a	neck	dissection	as	a	second	procedure,	and	six	elected	to	
not	have	a	neck	dissection.	The	differences	in	practice	patterns	





patient	morbidity,	 reported	 rates	 of	 unknown	 primary	 in	 the	
contralateral	lingual	tonsil	are	10%	(18).
Table 4 | Proportion of patients without suspicious findings on diagnostic workup and identification in the lingual tonsil.
reference institution Proportion with 
suspicious findings
Proportion without suspicious 
findings on PeT/cT, eUa with biopsy, 
and palatine tonsillectomy
identification in 
lingual tonsil after 
negative workup
Mehta et al. (1) University of Pittsburgh Medical Center 4/10 6/10 5/6
Patel et al. (14) University of Washington Medical Center 32/47 15/47 8/14
MD Anderson Cancer Center
University of Alabama Birmingham
University of Texas Medical School at Houston
Johns Hopkins Hospital
Oregon Health & Sciences University
Nagel et al. (17) Mayo Clinic Arizona 30/52 22/52 8/14
Sudoko et al. (the 
current study)
Dartmouth-Hitchcock Medical Center 0/16 16/16 4/16
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